Click for best price
Hemoglobinopathy Drugs Market Size, Share 2022
Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin.?
This report contains market size and forecasts of Hemoglobinopathy Drugs in Global, including the following market information:
Global Hemoglobinopathy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hemoglobinopathy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hydroxyurea Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemoglobinopathy Drugs include Novartis, AstraZeneca, Bluebird, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company and Celgene. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hemoglobinopathy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoglobinopathy Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hemoglobinopathy Drugs Market Segment Percentages, by Type, 2021 (%)
Hydroxyurea
Glutamine
Zynteglo
Other
Global Hemoglobinopathy Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hemoglobinopathy Drugs Market Segment Percentages, by Application, 2021 (%)
Sickle Cell Diseases
Thalassemia
Global Hemoglobinopathy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hemoglobinopathy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoglobinopathy Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hemoglobinopathy Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
AstraZeneca
Bluebird
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene
| Report Attributes |
Report Details |
| Report Title |
Hemoglobinopathy Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hemoglobinopathy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemoglobinopathy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemoglobinopathy Drugs Overall Market Size
2.1 Global Hemoglobinopathy Drugs Market Size: 2021 VS 2028
2.2 Global Hemoglobinopathy Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemoglobinopathy Drugs Players in Global Market
3.2 Top Global Hemoglobinopathy Drugs Companies Ranked by Revenue
3.3 Global Hemoglobinopathy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Hemoglobinopathy Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemoglobinopathy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemoglobinopathy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Hemoglobinopathy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemoglobinopathy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hemoglobinopathy Drugs Market Size Markets, 2021 & 2028
4.1.2 Hydroxyurea
4.1.3 Glutamine
4.1.4 Zynteglo
4.1.5 Other
4.2 By Type - Global Hemoglobinopathy Drugs Revenue & Forecasts
4.2.1 By Type - Global Hemoglobinopathy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Hemoglobinopathy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hemoglobinopathy Drugs Market Size, 2021 & 2028
5.1.2 Sickle Cell Diseases
5.1.3 Thalassemia
5.2 By Application - Global Hemoglobinopathy Drugs Revenue & Forecasts
5.2.1 By Application - Global Hemoglobinopathy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Hemoglobinopathy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hemoglobinopathy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Hemoglobinopathy Drugs Revenue & Forecasts
6.2.1 By Region - Global Hemoglobinopathy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Hemoglobinopathy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hemoglobinopathy Drugs Revenue, 2017-2028
6.3.2 US Hemoglobinopathy Drugs Market Size, 2017-2028
6.3.3 Canada Hemoglobinopathy Drugs Market Size, 2017-2028
6.3.4 Mexico Hemoglobinopathy Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hemoglobinopathy Drugs Revenue, 2017-2028
6.4.2 Germany Hemoglobinopathy Drugs Market Size, 2017-2028
6.4.3 France Hemoglobinopathy Drugs Market Size, 2017-2028
6.4.4 U.K. Hemoglobinopathy Drugs Market Size, 2017-2028
6.4.5 Italy Hemoglobinopathy Drugs Market Size, 2017-2028
6.4.6 Russia Hemoglobinopathy Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Hemoglobinopathy Drugs Market Size, 2017-2028
6.4.8 Benelux Hemoglobinopathy Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hemoglobinopathy Drugs Revenue, 2017-2028
6.5.2 China Hemoglobinopathy Drugs Market Size, 2017-2028
6.5.3 Japan Hemoglobinopathy Drugs Market Size, 2017-2028
6.5.4 South Korea Hemoglobinopathy Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Hemoglobinopathy Drugs Market Size, 2017-2028
6.5.6 India Hemoglobinopathy Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hemoglobinopathy Drugs Revenue, 2017-2028
6.6.2 Brazil Hemoglobinopathy Drugs Market Size, 2017-2028
6.6.3 Argentina Hemoglobinopathy Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hemoglobinopathy Drugs Revenue, 2017-2028
6.7.2 Turkey Hemoglobinopathy Drugs Market Size, 2017-2028
6.7.3 Israel Hemoglobinopathy Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Hemoglobinopathy Drugs Market Size, 2017-2028
6.7.5 UAE Hemoglobinopathy Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Hemoglobinopathy Drugs Major Product Offerings
7.1.4 Novartis Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.1.5 Novartis Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Hemoglobinopathy Drugs Major Product Offerings
7.2.4 AstraZeneca Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Bluebird
7.3.1 Bluebird Corporate Summary
7.3.2 Bluebird Business Overview
7.3.3 Bluebird Hemoglobinopathy Drugs Major Product Offerings
7.3.4 Bluebird Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.3.5 Bluebird Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Hemoglobinopathy Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Emmaus Medical
7.5.1 Emmaus Medical Corporate Summary
7.5.2 Emmaus Medical Business Overview
7.5.3 Emmaus Medical Hemoglobinopathy Drugs Major Product Offerings
7.5.4 Emmaus Medical Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.5.5 Emmaus Medical Key News
7.6 Acceleron Pharma
7.6.1 Acceleron Pharma Corporate Summary
7.6.2 Acceleron Pharma Business Overview
7.6.3 Acceleron Pharma Hemoglobinopathy Drugs Major Product Offerings
7.6.4 Acceleron Pharma Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.6.5 Acceleron Pharma Key News
7.7 HemaQuest Pharmaceuticals
7.7.1 HemaQuest Pharmaceuticals Corporate Summary
7.7.2 HemaQuest Pharmaceuticals Business Overview
7.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Major Product Offerings
7.7.4 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.7.5 HemaQuest Pharmaceuticals Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Hemoglobinopathy Drugs Major Product Offerings
7.8.4 Eli Lilly and Company Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly and Company Key News
7.9 Celgene
7.9.1 Celgene Corporate Summary
7.9.2 Celgene Business Overview
7.9.3 Celgene Hemoglobinopathy Drugs Major Product Offerings
7.9.4 Celgene Hemoglobinopathy Drugs Revenue in Global Market (2017-2022)
7.9.5 Celgene Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hemoglobinopathy Drugs Market Opportunities & Trends in Global Market
Table 2. Hemoglobinopathy Drugs Market Drivers in Global Market
Table 3. Hemoglobinopathy Drugs Market Restraints in Global Market
Table 4. Key Players of Hemoglobinopathy Drugs in Global Market
Table 5. Top Hemoglobinopathy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemoglobinopathy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemoglobinopathy Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemoglobinopathy Drugs Product Type
Table 9. List of Global Tier 1 Hemoglobinopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemoglobinopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hemoglobinopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemoglobinopathy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemoglobinopathy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hemoglobinopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemoglobinopathy Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemoglobinopathy Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hemoglobinopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemoglobinopathy Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemoglobinopathy Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemoglobinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemoglobinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemoglobinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemoglobinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemoglobinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Hemoglobinopathy Drugs Product Offerings
Table 32. Novartis Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Hemoglobinopathy Drugs Product Offerings
Table 35. AstraZeneca Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Bluebird Corporate Summary
Table 37. Bluebird Hemoglobinopathy Drugs Product Offerings
Table 38. Bluebird Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Hemoglobinopathy Drugs Product Offerings
Table 41. Bristol-Myers Squibb Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Emmaus Medical Corporate Summary
Table 43. Emmaus Medical Hemoglobinopathy Drugs Product Offerings
Table 44. Emmaus Medical Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Acceleron Pharma Corporate Summary
Table 46. Acceleron Pharma Hemoglobinopathy Drugs Product Offerings
Table 47. Acceleron Pharma Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 48. HemaQuest Pharmaceuticals Corporate Summary
Table 49. HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Product Offerings
Table 50. HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly and Company Corporate Summary
Table 52. Eli Lilly and Company Hemoglobinopathy Drugs Product Offerings
Table 53. Eli Lilly and Company Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Celgene Corporate Summary
Table 55. Celgene Hemoglobinopathy Drugs Product Offerings
Table 56. Celgene Hemoglobinopathy Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hemoglobinopathy Drugs Segment by Type in 2021
Figure 2. Hemoglobinopathy Drugs Segment by Application in 2021
Figure 3. Global Hemoglobinopathy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemoglobinopathy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemoglobinopathy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemoglobinopathy Drugs Revenue in 2021
Figure 8. By Type - Global Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 12. US Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 24. China Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemoglobinopathy Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemoglobinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bluebird Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Emmaus Medical Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Acceleron Pharma Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly and Company Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Celgene Hemoglobinopathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
